Literature DB >> 21126779

ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon.

Natalie Cutri, Christopher Zeitz, Angela M Kucia, John F Beltrame.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21126779     DOI： 10.1016/j.ijcard.2010.10.120

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

Review 1.  The coronary slow flow phenomenon: characteristics, mechanisms and implications.

Authors:  Xiao Wang; Shao-Ping Nie
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

2.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

3.  The association of serum albumin with coronary slow flow.

Authors:  Mustafa Cetin; Cemil Zencir; Hakan Tasolar; Erkan Baysal; Mehmet Balli; Erdal Akturk
Journal:  Wien Klin Wochenschr       Date:  2014-07-01       Impact factor: 1.704

4.  Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity.

Authors:  E Melles; H Jörnvall; S Tryggvason; K Gemzell Danielsson; K Ekberg; K Tryggvason; J Wahren; T Bergman
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

5.  Echocardiographic and laboratory findings in coronary slow flow phenomenon: cross-sectional study and review.

Authors:  Mir Hosein Seyyed Mohammadzad; Kamal Khademvatani; Salar Gardeshkhah; Amin Sedokani
Journal:  BMC Cardiovasc Disord       Date:  2021-05-05       Impact factor: 2.298

6.  Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians.

Authors:  Yeganeh Karimi; Fatemeh Sehati; Ali Sarreshtedari; Mina Mirzad; Yasaman Khalili; Reza Kiani; Elham Taheri Bajgan; Maryam Hosseini Moghadam; Farzaneh Mehrvarz; Hooman Bakhshandeh; Maryam Parham; Mahshid Malakootian; Parham Sadeghipour
Journal:  BMC Cardiovasc Disord       Date:  2022-06-30       Impact factor: 2.174

7.  Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow.

Authors:  Hongmei Niu; Zhenzhen Wei; Yanling Zhang; Jian He; Danyan Jia
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

8.  Value of exercise stress electrocardiography for stratification of exercise capacity and left ventricular systolic and diastolic function on coronary slow flow: case-control study.

Authors:  Yonghuai Wang; Jinyang Li; Shuang Liu; Lixin Mu; Guangyuan Li; Hang Yu; Jun Yang; Chunyan Ma
Journal:  BMC Cardiovasc Disord       Date:  2019-12-12       Impact factor: 2.298

9.  Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis.

Authors:  Lihua Sun; Ying Zhang; Junshi Zhang; Juan Wang; Shifeng Xing
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

10.  Myocardial Infarction Secondary to Marijuana-Induced Coronary Vasospasm.

Authors:  Krunal H Patel; Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Nabila Khondakar; Madina Abduraimova; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2020-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.